Immunotherapy News and Research

Latest Immunotherapy News and Research

Asthmatic adolescents develop greater dependence to nicotine compared to healthy counterparts

Curiosity is a driving factor in why most kids start smoking, and the same is true for kids with asthma.

11 Nov 2016

New guidelines offer way for parents to introduce peanut-containing foods to reduce allergy risk

Parents may be confused with how and when to introduce peanut-containing foods to their infants.

11 Nov 2016

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV, according to two related studies from Perelman School of Medicine at the University of Pennsylvania, the University of Alabama at Birmingham, and the National Institutes of Health.

9 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy - a new approach to treating cancer by boosting a patient's immune system -- may fail in a substantial number of patients.

8 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.

7 Nov 2016

Gut microbiome may help improve immunotherapy response in melanoma patients

Patients with malignant melanoma - whose disease has spread - are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.

6 Nov 2016

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

5 Nov 2016

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Combination therapy utilizing two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response.

4 Nov 2016

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson Cancer Research Center today announced the official opening of a first-of-its-kind clinic dedicated to providing innovative immunotherapies for cancer patients in clinical trials.

2 Nov 2016

Researchers develop new way to test strength of immune response

The immune system orchestrates large and small scale attacks on innumerous targets: viruses, bacteria, cancer, but it also misfires causing allergy or autoimmune reactions.

27 Oct 2016

Wearable patch shows promise for treating children with peanut allergy

A wearable patch that delivers small amounts of peanut protein through the skin shows promise for treating children and young adults with peanut allergy, with greater benefits for younger children, according to one-year results from an ongoing clinical trial.

26 Oct 2016

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC).

25 Oct 2016

New approach could overcome large immunosuppressive tumors

Harnessing the body's own immune system to destroy tumors is a tantalizing prospect that has yet to realize its full potential. However, a new advance from MIT may bring this strategy, known as cancer immunotherapy, closer to becoming reality.

24 Oct 2016

Identification of new lung cancer subtypes could lead to personalized immunotherapies

Personalized therapies can potentially improve the outcomes of patients with lung cancer, but how to best design such an approach is not always clear.

24 Oct 2016

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

A table-top device that enables medical staff to genetically manipulate a patient's blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multi-million-dollar "clean rooms," making gene therapy more possible for even the poorest of countries.

24 Oct 2016

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.

24 Oct 2016

Sanford opens new immunotherapy study on colorectal cancer

Sanford Health has opened another clinical trial exploring the power of the body's immune system to fight cancer.

21 Oct 2016

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

In efforts to develop new treatments for brain cancer, scientists from Johns Hopkins Drug Discovery and the Kimmel Cancer Center's Bloomberg~Kimmel Institute for Cancer Immunotherapy report they have altered the structure of an experimental drug that seems to enhance its ability to slip through the mostly impermeable blood-brain barrier.

20 Oct 2016

Immunotherapy News and Research

Latest Immunotherapy News and Research

Asthmatic adolescents develop greater dependence to nicotine compared to healthy counterparts

New guidelines offer way for parents to introduce peanut-containing foods to reduce allergy risk

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

Gut microbiome may help improve immunotherapy response in melanoma patients

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Immune checkpoint cancer therapies may cause rare cardiac side effects linked to unexpected immune response

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Researchers develop new way to test strength of immune response

Wearable patch shows promise for treating children with peanut allergy

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

New approach could overcome large immunosuppressive tumors

Identification of new lung cancer subtypes could lead to personalized immunotherapies

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

Sanford opens new immunotherapy study on colorectal cancer

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in